Our study confirmed MAFG overexpression both in mRNA and protein levels in HCC, and its promoting role for advanced tumor grade, TNM stage, tumor invasion and dismal prognosis in HCC patients. This evidence concerns the gene MAFG and hepatocellular carcinoma.